These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37491060)
1. [Neuroimaging of Pituitary Neuroendocrine Tumors]. Kurosaki M No Shinkei Geka; 2023 Jul; 51(4):634-641. PubMed ID: 37491060 [TBL] [Abstract][Full Text] [Related]
2. Up-To-Date Magnetic Resonance Imaging Findings for the Diagnosis of Hypothalamic and Pituitary Tumors. Kurosaki M; Sakamoto M; Kambe A; Ogura T Yonago Acta Med; 2021 May; 64(2):155-161. PubMed ID: 34025189 [TBL] [Abstract][Full Text] [Related]
4. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Asa SL; Mete O; Riddle ND; Perry A Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858 [TBL] [Abstract][Full Text] [Related]
5. [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)]. Nagamine T; Fukuda I No Shinkei Geka; 2023 Jul; 51(4):706-715. PubMed ID: 37491068 [TBL] [Abstract][Full Text] [Related]
6. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors. Kara M; Tokat F; Pamir MN; Danyeli AE Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655 [TBL] [Abstract][Full Text] [Related]
7. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors. Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356 [TBL] [Abstract][Full Text] [Related]
8. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease. Rak B; Maksymowicz M; Pękul M; Zieliński G Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861 [TBL] [Abstract][Full Text] [Related]
9. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions. Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236 [TBL] [Abstract][Full Text] [Related]
10. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers. Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841 [No Abstract] [Full Text] [Related]
11. Application of magnetic resonance 3D-SPACE sequence combined image fusion technique in preoperative evaluation of pituitary macroadenoma. Nie J; Meng L; Li Z; Zhou G Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):980-987. PubMed ID: 33053542 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of pituitary high-resolution 3D MRI with deep-learning-based reconstruction for perioperative evaluation of pituitary adenomas. Ishimoto Y; Ide S; Watanabe K; Oyu K; Kasai S; Umemura Y; Sasaki M; Nagaya H; Tatsuo S; Nozaki A; Ikushima Y; Wakayama T; Asano K; Saito A; Tomiyama M; Kakeda S Neuroradiology; 2024 Jun; 66(6):937-945. PubMed ID: 38374411 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI. Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094 [TBL] [Abstract][Full Text] [Related]
15. Is radiomics a useful addition to magnetic resonance imaging in the preoperative classification of PitNETs? Sathya A ; Goyal-Honavar A; Chacko AG; Jasper A; Chacko G; Devakumar D; Seelam JA; Sasidharan BK; Pavamani SP; Thomas HMT Acta Neurochir (Wien); 2024 Feb; 166(1):91. PubMed ID: 38376544 [TBL] [Abstract][Full Text] [Related]
16. Multiple tumorous lesions of the pituitary gland. Schöning JV; Flitsch J; Lüdecke DK; Fahlbusch R; Buchfelder M; Buslei R; Knappe UJ; Bergmann M; Schulz-Schaeffer WJ; Herms J; Glatzel M; Saeger W Hormones (Athens); 2022 Dec; 21(4):653-663. PubMed ID: 35947342 [TBL] [Abstract][Full Text] [Related]
17. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion. Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693 [TBL] [Abstract][Full Text] [Related]
18. Pangenomic Classification of Pituitary Neuroendocrine Tumors. Neou M; Villa C; Armignacco R; Jouinot A; Raffin-Sanson ML; Septier A; Letourneur F; Diry S; Diedisheim M; Izac B; Gaspar C; Perlemoine K; Verjus V; Bernier M; Boulin A; Emile JF; Bertagna X; Jaffrezic F; Laloe D; Baussart B; Bertherat J; Gaillard S; Assié G Cancer Cell; 2020 Jan; 37(1):123-134.e5. PubMed ID: 31883967 [TBL] [Abstract][Full Text] [Related]
19. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors. Alshaikh OM; Asa SL; Mete O; Ezzat S Endocr Pathol; 2019 Jun; 30(2):118-127. PubMed ID: 30706322 [TBL] [Abstract][Full Text] [Related]